Vancomycin Taper to Prevent Recurrent Clostridioides Difficile | MicrobiomeTrials← Back to trialsNCT07328971
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-24Est. Completion: 2030-06-01
Enrollment target: 500 participants Locations- McGill University Health Centre, Montreal, Quebec, Canada
Other microbiome trials you might be interested in
Lower Urinary Tract Obstruction, Congenital
The purpose of this research is to determine the feasibility and safety of performing fetal operative cystoscopy for the…
Rochester, United StatesCompleted Mar 23, 2056
Severe Community-acquired Pneumonia
Severe community-acquired pneumonia (CAP) and community-acquired aspiration pneumonia (CAAP) are common reasons for adul…
Toulon, FranceCompleted Sep 30, 2025